Digital Three-dimensional Imaging Models for Repair of Complex Long Bone Fractures
NCT ID: NCT02964754
Last Updated: 2018-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2014-12-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
NCT06269354
Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures
NCT06713031
Platelet-rich Plasma Combined With Conventional Surgery in the Treatment of Atrophic Nonunion of Femoral Shaft Fractures
NCT03129971
3D-printed Bone Models in Addition to CT Imaging for Intra-articular Fracture Repair
NCT04748016
Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques
NCT02845245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adverse events
1. The investigators will record adverse events, including screw loosening and falling off, steel plate fracture and bending, joint stiffness, delayed healing or non-healing, peripheral nerve injury and infection.
2. If severe adverse events occur, investigators will report details, including the date of occurrence and measures taken to treat the adverse events, to the principle investigator and the institutional review board within 24 hours.
Data collection, management, analysis and open-access
1. Data collection: Case report forms with demographic data, disease diagnosis, accompanying diseases, drug allergy history, and adverse events will be collected, processed using Epidata software (Epidata Association, Odense, Denmark), collated, and then recorded electronically by data managers using a double-data entry strategy.
2. Data management: The locked electronic database will be accessible and locked only by the project manager, and will not be altered. All data regarding this trial will be preserved by the Affiliated Hospital of Qinghai University, China.
3. Data analysis: The electronic database will be statistically analyzed by a professional statistician who will create an outcome analysis report that will be submitted to the lead researchers. An independent data monitoring committee will supervise and manage the trial data, ensuring a scientific and stringent trial to yield accurate and complete data.
4. Data open access: Anonymized trial data will be published at www.figshare.com.
Statistical analysis
1. Statistical analysis will be performed using SPSS 19.0 software, and will follow the intention-to-treat principle. Normally distributed measurement data will be expressed as mean ± standard deviation, and minimums and maximums. Non-normally distributed measurement data will be expressed as lower quartile (q1), and median and upper quartile (q3).
2. Fisher's exact test will be performed for comparison of total efficacy and the incidence of adverse reactions preoperatively and 6 months postoperatively. Mann Whitney U test will be used to compare Harris score, Visual Analogue Scale, operation time and hospital stay between the two groups. The significance level will be α = 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the observation group
32 patients with complex long bone fractures will be randomized to undergo digital three-dimensional models will be established by CT scan for internal fixation in the observation group.
CT scan for internal fixation
In the observation group, digital three-dimensional models will be established by CT scan for internal fixation.
the control group
31 patients will be randomized to undergo conventional internal fixation in the control group.
conventional internal fixation
In the control group, patients will undergo conventional internal fixation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT scan for internal fixation
In the observation group, digital three-dimensional models will be established by CT scan for internal fixation.
conventional internal fixation
In the control group, patients will undergo conventional internal fixation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with complex long bone fractures via X-ray
* Admission within 6 hours after injury
Exclusion Criteria
* Split fractures of the humeral head
* Neer IV fractures
* Humeral head compression area greater than 40%
* Glenohumeral dislocation
* Conscious disturbance, cerebral infarction, tumor, serious medical complications, such as heart, lung, kidney failure, severe hypertension, diabetes and blood diseases
* History of elbow joint dysfunction or shoulder joint disease
* Unwilling to sign the informed consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qinghai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zichun Zhao
Associate Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zichun Zhao, Master
Role: PRINCIPAL_INVESTIGATOR
Affiliated Hospital of Qinghai University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QinghaiUH_006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.